The rationale for this, first of all, is that as an agency who will be regulating in these highly scientific areas, it's vital that we have a very strong evidence base on which to base things.
We knew that CIHR has just finished funding, over the last several years, a healthy embryo research project, and this was an opportunity for us to perhaps provide some funding to ensure that the information from that project would be translated to the appropriate stakeholders so that it could be utilized.